INVN - ETF AI Analysis
Top Page
Alger Russell Innovation ETF (INVN)
Rating:69Neutral
Price Target:―
Positive Factors
Balanced Top Holdings Performance
Several of the largest positions, such as Corcept Therapeutics, Cirrus Logic, Etsy, and Zoom, have shown strong gains, helping offset weaker names in the portfolio.
Focused Innovation Sectors
The ETF is heavily invested in technology and health care, giving investors targeted exposure to companies that aim to benefit from long-term innovation trends.
Clear U.S. Market Focus
With almost all assets in U.S. companies, the fund offers straightforward exposure to the U.S. innovation and growth market without added currency risk.
Negative Factors
Recent Weak Overall Performance
The ETF’s returns over the year to date and recent three-month period have been weak, which may concern investors looking for steadier momentum.
High Concentration in a Few Growth Sectors
Large weights in technology and health care mean the fund could be hit hard if growth or innovation-related stocks fall out of favor.
Moderately High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which can eat into returns over time compared with lower-cost alternatives.
INVN vs. SPDR S&P 500 ETF (SPY)
AUM10.14M
RegionNorth America
Expense Ratio0.55%
Beta0.99
IssuerAlger
Inception DateJan 07, 2025
Dividend Yield0.27%
Asset ClassEquity
Index TrackedAlger Russell Innovation Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,831
30 Day Avg. Volume3,697
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
27.77Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering50
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
INVN Summary
The Alger Russell Innovation ETF (INVN) tracks the Alger Russell Innovation Index and focuses on large U.S. companies that are seen as leaders in new technology and modern business models. It holds well-known names like Zoom Video Communications and PayPal, along with other tech, health care, and consumer-focused firms. Someone might invest in this ETF to seek long-term growth by spreading their money across many innovative companies instead of picking individual stocks. However, it is heavily tilted toward technology and growth stocks, so its price can swing a lot and may drop sharply when these types of companies fall out of favor.
How much will it cost me?The Alger Russell Innovation ETF (Ticker: INVN) has an expense ratio of 0.55%, which means you’ll pay $5.50 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, focusing on innovative large-cap companies rather than tracking a broad index. Active management typically involves higher costs due to research and portfolio adjustments.
What would affect this ETF?The Alger Russell Innovation ETF could benefit from continued advancements in technology and healthcare, as these sectors make up a significant portion of its portfolio and are often drivers of innovation. However, rising interest rates or economic slowdowns may negatively impact growth-focused companies, particularly in consumer cyclical and technology sectors. Regulatory changes or geopolitical tensions in the U.S., where the ETF is primarily focused, could also influence its performance.
INVN Top 10 Holdings
This innovation-focused ETF leans heavily on U.S. tech and health care, with names like Corcept Therapeutics, Okta, and NetApp doing much of the heavy lifting as their shares have been steadily rising on solid growth stories. Qualcomm has also been a strong but occasionally choppy contributor, riding the broader semiconductor and AI wave. On the flip side, Duolingo and Unity look more like problem children for now, with weaker year-to-date trends tugging at returns. Overall, it’s a concentrated bet on North American innovators, especially in technology-led themes.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Roblox | 2.44% | $247.45K | $39.40B | -51.57% | 51 Neutral | |
| CCC Intelligent Solutions Holdings | 2.44% | $247.45K | $3.66B | -35.70% | 61 Neutral | |
| Bill.com Holdings | 2.43% | $246.43K | $4.27B | -8.98% | 74 Outperform | |
| Zebra Tech | 2.26% | $229.19K | $12.70B | -18.60% | 72 Outperform | |
| Expedia | 2.23% | $226.15K | $31.88B | 48.77% | 80 Outperform | |
| Klaviyo, Inc. Class A | 2.21% | $224.12K | $5.23B | -44.59% | 72 Outperform | |
| Figma, Inc. Class A | 2.20% | $223.11K | $12.50B | ― | ― | |
| Block | 2.17% | $220.06K | $46.85B | 21.18% | 72 Outperform | |
| Gitlab | 2.16% | $219.05K | $5.65B | -23.12% | 62 Neutral | |
| Maplebear | 2.15% | $218.04K | $11.35B | -1.97% | 79 Outperform |
INVN Technical Analysis
Positive
―
Price Trends
21.28
Positive
20.19
Positive
20.59
Positive
Market Momentum
0.47
Negative
63.77
Neutral
75.03
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For INVN, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 21.70, equal to the 50-day MA of 21.28, and equal to the 200-day MA of 20.59, indicating a bullish trend. The MACD of 0.47 indicates Negative momentum. The RSI at 63.77 is Neutral, neither overbought nor oversold. The STOCH value of 75.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for INVN.
INVN Peer Comparison
Comparison Results
Performance Comparison
INVN
Alger Russell Innovation ETF
22.89
3.60
18.66%
ACEP
ARS Core Equity Portfolio ETF
―
―
―
JOYT
JPMorgan Equity and Options Total Return ETF
―
―
―
JHDG
John Hancock Hedged Equity ETF
―
―
―
FCUS
Pinnacle Focused Opportunities ETF
―
―
―
EGGQ
NestYield Visionary ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents